Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-05-29T05:50:18.672Z Has data issue: false hasContentIssue false

126 A CTS team approach to reliable delivery of aerosols to lung cells at the air-liquid interface (ALI), through Dosimetric Aerosol in Vitro Inhalation Device (DAVID)

Published online by Cambridge University Press:  24 April 2023

Sripriya Nannu Shankar
Affiliation:
Department of Environmental Engineering Sciences, University of Florida, Gainesville, USA
Amber O’Connor
Affiliation:
Department of Environmental & Global Health, University of Florida, Gainesville, USA
Eric Le
Affiliation:
Department of Chemical Engineering, University of Florida, Gainesville, USA
Alex Theodore
Affiliation:
Department of Environmental Engineering Sciences, University of Florida, Gainesville, USA
Tara Sabo-Attwood
Affiliation:
Department of Environmental & Global Health, University of Florida, Gainesville, USA
Gregory S. Lewis
Affiliation:
Aerosol Dynamics Inc., Berkeley, USA
Arantzazu-Eiguren Fernandez
Affiliation:
Aerosol Dynamics Inc., Berkeley, USA
Chang-Yu Wu
Affiliation:
Department of Environmental Engineering Sciences, University of Florida, Gainesville, USA
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

OBJECTIVES/GOALS: In vitro models that mimic the human respiratory system are needed to assess the toxicity of inhaled contaminants. Therefore, our goal is to establish a Dosimetric Aerosol in-Vitro Inhalation Device (DAVID) that delivers aerosols in different patterns to human lung cells cultured at an air-liquid interface (ALI). METHODS/STUDY POPULATION: The collection unit of DAVID was modified in this study to accommodate different deposition patterns (spots, annular ring, rectangle & circle). CuO aerosols of varying concentrations were generated using a 6-jet Collison nebulizer for varying time periods to achieve different doses. To quantify the doses that were delivered to cells, the samples were digested with nitric acid & analyzed by Inductively Coupled Plasma-Optical Emission Spectrometry. Following the exposure of A549 cells to CuO aerosols, cytotoxicity and mRNA expression (i.e., HMOX1 & IL-8) will be assessed via LDH and RT-qPCR to determine the effect of regional (mass deposited/area of the pattern) and global (mass deposited/area of the cell culture insert) doses in cells. RESULTS/ANTICIPATED RESULTS: The deposition areas covered by rectangular, spot, annular ring, and circular patterns are estimated to be 6, 17, 27 and 85% of the insert’s surface area, onto which cells are cultured. Results for the patterns tested (spots and annular ring) show that both the regional and global doses were greater for spots than annular ring. Also, the regional doses were higher than global doses. Irrespective of the patterns, the global doses were the same for nebulizer suspensions of 0.1-1 mg/mL. Statistical analysis by ANOVA revealed there was no significant difference in doses between replicate inserts used in the same trial. We anticipate that regional doses with aerosol deposition to a larger surface area of the cell culture insert will correspond with higher cytotoxicity and mRNA expression of HMOX1 and IL-8 in cells. DISCUSSION/SIGNIFICANCE: There are limited in vitro exposure systems that can efficiently deliver aerosols to lung cells, while also mimicking inhalation by humans. In addition to addressing this knowledge gap, we will show the role of regional & global doses in studying cellular response & the ability of DAVID to deliver aerosols in different deposition patterns.

Type
Evaluation
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (https://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Author(s), 2023. The Association for Clinical and Translational Science